posted on 2023-03-31, 01:46authored byYulia Newton, Adam M. Novak, Teresa Swatloski, Duncan C. McColl, Sahil Chopra, Kiley Graim, Alana S. Weinstein, Robert Baertsch, Sofie R. Salama, Kyle Ellrott, Manu Chopra, Theodore C. Goldstein, David Haussler, Olena Morozova, Joshua M. Stuart
<p>Supplemental Table 1A: Differential expression scores used in the pan-cancer cluster GSEA analysis. These scores represent integrated t-statistic scores from the differential analysis within each tissue (see Supplemental Methods). Supplemental Table 1B: Full results of the GSEA analysis of the pan-cancer cluster, based on differential expression scores. Supplemental Table 1C: Per-sample ESTIMATE scores used in analysis of the pan-cancer cluster. Supplemental Table 1D: Per-sample surrogate purity scores used in analysis of the pan-cancer cluster. Supplemental Table 1E: List of genes located on sex chromosomes that were excluded from the methylation dataset in order to analyze only autosomal gene features. Supplemental Table 1F: Attributes available in the TumorMap that annotate metadata of the samples, along with descriptions of those attributes. Supplemental Table 1G: Statistical tests computed by different attribute enrichment analysis (AEA) tools available in the TumorMap. Supplemental Table 1H: List of 82 samples in the pan-cancer cluster in the integrated map as well as tissue composition, along with the number of samples, in the integrated pan-cancer cluster. Supplemental Table 1I: Input data for the LAML survival analysis.</p>
Funding
National Cancer Institute
National Human Genome Research Institute
National Institute for General Medical Sciences
National Science Foundation Office of Cyberinfrastructure CAREER
Cancer – Prostate Cancer Foundation Prostate Dream Team
St. Baldricks Foundation Treehouse Childhood Cancer